Fluid Therapy and the Use of Inotropes and Vasopressors in Pediatric Septic Shock

Septic shock in children represents a critical manifestation of sepsis, defined by cardiovascular insufficiency and impaired tissue perfusion. Management requires prompt recognition and the coordinated use of fluid therapy, inotropes, and vasopressors. Early interventions directly influence morbidity and mortality, as delays can exacerbate multi-organ dysfunction. The cornerstone of initial management is rapid administration of intravenous fluids. Current pediatric recommendations suggest an initial bolus of ۱۰-۲۰ mL/kg over ۵-۱۰ minutes, repeated as necessary up to ۶۰ mL/kg in the first hour. Crystalloids, such as normal saline or balanced buffered solutions, are preferred. Fluid responsiveness should be reassessed after each bolus to avoid overload, as excessive administration may precipitate pulmonary edema or worsen myocardial dysfunction. The principle is not simply to restore blood pressure but to optimize tissue perfusion, assessed by capillary refill, urine output, and mental status. Emerging concepts such as the use of capillary refill time (CRT) as a resuscitation endpoint highlight the value of simple bedside tools to tailor fluid therapy. Inotropes and vasopressors. If fluid resuscitation fails to restore adequate perfusion, vasoactive medications must be initiated. Norepinephrine is the vasopressor of first choice when vasoplegia predominates, as it improves mean arterial pressure and venous return. Epinephrine may be used when myocardial dysfunction is present, offering both inotropic and vasoconstrictive properties. Dobutamine remains a key inotrope for septic cardiomyopathy, particularly in children with depressed ventricular function, though its vasodilatory effects require caution. Vasopressin can be added as a second-line agent in fluid-refractory shock, especially when norepinephrine requirements are high. Recent evidence suggests that early, concomitant initiation of vasopressors with fluids may reduce fluid overload, shorten hypotension, and lower complication rates. Individualized targets, such as diastolic shock index or microcirculatory parameters, are under investigation to guide therapy more precisely. In pediatric practice, the integration of bedside echocardiography and near-continuous monitoring tools provides an opportunity for more nuanced titration of both fluids and vasoactive drugs. The management of septic shock in children requires a dynamic balance: rapid but cautious fluid resuscitation, timely escalation to inotropes and vasopressors, and continuous reassessment of hemodynamic status. While crystalloid boluses remain the initial step, the early introduction of norepinephrine or epinephrine in refractory cases, along with selective use of dobutamine, forms the backbone of modern pediatric septic shock therapy. Individualized strategies and evolving resuscitation targets continue to refine outcomes in this vulnerable population.